Cargando…
Exploiting the Indole Scaffold to Design Compounds Binding to Different Pharmacological Targets †
Several indole derivatives have been disclosed by our research groups that have been collaborating for nearly 25 years. The results of our investigations led to a variety of molecules binding selectively to different pharmacological targets, specifically the type A γ-aminobutyric acid (GABA(A)) chlo...
Autores principales: | Taliani, Sabrina, Da Settimo, Federico, Martini, Claudia, Laneri, Sonia, Novellino, Ettore, Greco, Giovanni |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7287756/ https://www.ncbi.nlm.nih.gov/pubmed/32429433 http://dx.doi.org/10.3390/molecules25102331 |
Ejemplares similares
-
Indol-3-ylglyoxylamide as Privileged Scaffold in Medicinal Chemistry
por: Barresi, Elisabetta, et al.
Publicado: (2023) -
Identification of novel indole derivatives acting as inhibitors of the Keap1–Nrf2 interaction
por: Cosimelli, Barbara, et al.
Publicado: (2019) -
Long lasting MDM2/Translocator protein modulator: a new strategy for irreversible apoptosis of human glioblastoma cells
por: Daniele, Simona, et al.
Publicado: (2016) -
Target-Based Anticancer Indole Derivatives for the Development of Anti-Glioblastoma Agents
por: Salerno, Silvia, et al.
Publicado: (2023) -
Allosterism vs. Orthosterism: Recent Findings and Future Perspectives on A(2B) AR Physio-Pathological Implications
por: Barresi, Elisabetta, et al.
Publicado: (2021)